NRH:quinone oxidoreductase 2 (NQO2) is a cytosolic flavoprotein that catalyzes the two-electron reduction of quinones and quinoid compounds to hydroquinones. Although the role of a homologue, NAD(P)H:quinone oxidoreductase 1 (NQO1), is well defined in oxidative stress, neoplasia, and carcinogenesis, little is known about the mechanism of actions of NQO2 in these cellular responses. Whether NQO2 has any role in tumor necrosis factor (TNF) signaling was investigated using keratinocytes derived from wild-type and NQO2 knockout (NQO2 À/À ) mice. Although exposure of wild-type cells to TNF led to activation of nuclear factor-KB (NF-KB) and IKBA kinase, IKBA degradation, p65 phosphorylation, and p65 nuclear translocation, this cytokine had no effect on NQO2 À/À cells. Deletion of NQO2 also abolished TNF-induced c-Jun NH 2 -terminal kinase, Akt, p38, and p44/p42 mitogen-activated protein kinase activation. The induction of various antiapoptotic gene products (MMP-9, cyclin D1, COX-2, IAP1, IAP2, Bcl-2, cFLIP, and XIAP) by TNF was also abolished in NQO2 À/À cells. This correlated with potentiation of TNF-induced apoptosis as indicated by cell viability, Annexin V staining, and caspase activation. In agreement with this, we also found that TNF activated NQO2, and NQO2-specific small interfering RNA abrogated the TNF-induced NQO2 activity and NF-KB activation. Overall, our results indicate that deletion of NQO2 plays a differential role in TNF signaling pathway: by suppressing cell survival signals and potentiating TNF-induced apoptosis.
Introduction
NRH:quinone oxidoreductase 2 (NQO2) is a flavoprotein that catalyzes metabolic reduction of quinones (1) (2) (3) . It is a homologue of the well-characterized NAD(P)H:quinone oxidoreductase 1 (NQO1). The two proteins possess f49% amino acid sequence identity and have similar substrate specificities, but differ in affinity for electron-donating cofactors. Although NQO2 is resistant to typical inhibitors of NQO1, such as dicumarol, NQO2 is inhibited by flavones such as quercetin and benzo(a)pyrene (1) (2) (3) (4) (5) . The cDNA and gene encoding NQO2 were identified from human liver (4, 5) . NQO2 À/À mice have been shown to develop normally, indicating that NQO2 is not associated with mouse development (6) , but deletion of the gene has been reported to cause myelogenous hyperplasia of bone marrow, decrease sensitivity to menadioneinduced hepatic toxicity (6) , and increase susceptibility to benzo(a)pyrene-induced and 7,12-dimethylbenz(a)anthraceneinduced skin carcinogenesis (7) , suggesting that NQO2 plays an important role in protection against myelogenous hyperplasia and in chemoprevention. NQO1 À/À mice, on the other hand, showed altered intracellular redox status and altered metabolism of carbohydrates, fatty acids, and nucleotides and reduced accumulation of abdominal fat with age (8) . NQO1 À/À mice, in contrast to NQO2 À/À mice, showed increased sensitivity to menadioneinduced hepatic damage (6) . Like NQO2 À/À mice, NQO1
À/À mice also developed myelogenous hyperplasia of bone marrow and increased sensitivity to skin carcinogenesis in response to benzo(a)pyrene and dimethylbenz(a)anthracene (9) . Although NQO1 protein is expressed in most tumor cells (10) (11) (12) (13) , information about expression of NQO2 protein in tumor tissues is still limited in spite of many studies (5, (14) (15) (16) . Our previous report has been shown that the deletion of NQO1 gene potentiates tumor necrosis factor (TNF)-induced apoptosis through down-modulation of nuclear factor-nB (NF-nB)-regulated gene products (17) . It is evident that there are more similarities than dissimilarities between NQO1 and NQO2, and it is plausible to assume that the NQO2 too has a role in tumorigenesis.
TNF is one of the most potent proinflammatory cytokines. It is required for maintenance of immune system in normal conditions, but if it is dysregulated, it is associated with the proliferation, survival, invasion, angiogenesis, and metastasis of tumors (18) . Most of these TNF effects occur through the activation of NF-nB, activated protein 1 (AP-1), c-Jun NH 2 -terminal kinase (JNK), p38 mitogenactivated protein kinase (MAPK), p44/p42 MAPK, and Akt (18, 19) . Therefore, our purpose in this study was to determine the role of NQO2 in TNF cell signaling by using cells derived from NQO2 À/À mice. We found that NQO2 was required for the TNF-induced activation of NF-nB, InBa kinase (IKK), JNK, Akt, p38, and p44/p42 MAPK. We also found that NF-nB-regulated gene products, such as IAP1, IAP2, XIAP, Bcl-2, cFLIP, cyclin D1, cyclooxygenase (COX)-2, and metalloproteinase (MMP)-9, were down-regulated by the deletion of NQO2, which potentiated apoptosis. serum were obtained from Invitrogen. Anti-h-actin antibody was obtained from Sigma. The antibodies anti-NQO2 (N-15), anti-NQO1, anti-p65, anti-InBa, anti-Akt, anti-p44/p42, anti-p38, anti-cyclin D1, anti-MMP-9, anti-poly(ADP-ribose) polymerase (PARP), anti-IAP1, anti-IAP2, and antiBcl-2 were obtained from Santa Cruz Biotechnology. The anti-COX-2 and XIAP antibodies were obtained from BD Biosciences. Cell lines. Keratinocytes derived from benzo(a)pyrene-induced tumors in wild-type and NQO2-null mice were grown in monolayer by procedures previously described (17) . Briefly, the tumors were removed and placed in high calcium (200 mmol/L) supplemented with antibiotics and antimitotic agents. The tumors were exposed to collagenase at 37jC for 2 h with agitation. The settled clumps were gently removed from the supernatant, washed twice with high calcium buffer, exposed to high calcium/ keratinocyte growth factor, and plated in the four corner wells of collagen (Invitrogen)-coated 12-well plates. The medium was replaced with low calcium (50 mmol/L)/keratinocyte growth factor and replaced every 2 to 3 days. The growing keratinocyte cells were collected and cultured in DMEM supplemented with 10% FCS, 100 units/mL penicillin, and 100 Ag/mL streptomycin. The karyotyping analysis did not reveal loss and/or gain or translocation of chromosome (1) in established skin tumor cells (data not shown).
NQO2 enzyme activity. NQO2 activity was determined as described previously (6) . In brief, NRH was synthesized by adding 1,000 units of calf intestinal alkaline phosphatase (Sigma) to 500 AL of 10 mmol/L nicotinamide mononucleotide (Sigma) in PBS. The reaction was allowed to proceed for 15 min at room temperature. Ten microliters of the NRH were added to 50 mmol/L Tris (pH 7.4), 100 Amol/L dichlorophenolindophenol, and cytosolic extract in a 1-mL standard cuvette. Absorbance was monitored at 600 nm for 1 min with a Beckman DU640 spectrophotometer. Cytosolic extract concentrations were used that produced a 0.08 to 0.15 A change/min. This gave us total NQO activity. The same experiment was repeated in the presence of 10 Amol/L NQO2-specific inhibitor benzopyrene. The activity obtained in the presence of benzopyrene was subtracted from the total activity to obtain the benzopyrene-inhibitable NQO2 activity. The specific activity of NQO2 was calculated from the change in absorbance per microgram of protein. The experiments were independently repeated thrice.
Small interfering RNA inhibition of NQO2 activity and protein. Human hepatoblastoma (HepG2) cells were grown in monolayer cultures in six-well plates in MEM-a supplemented with 10% fetal bovine serum. Lamin A/C and NQO2 small interfering RNA (siRNA) was purchased from Dharmacon. The HepG2 cells were transfected with Lamin A/C or NQO2-specific siRNA using LipofectAMINE RNAiMAX from Invitrogen by using the procedure as suggested in the manufacturer's protocol. The cells were harvested and homogenized, and nuclear and cytosolic fractions were prepared using a kit and instruction manual from Active Motif. The cytosolic fractions were analyzed for NQO2 activity by using a previously described procedure, and NQO2 protein was analyzed by Western blotting and probing with anti-NQO2 antibody. The nuclear fractions were analyzed for NF-nB binding in electrophoretic mobility shift assay (EMSA) experiments.
Electrophoretic mobility shift assays. To assess NF-nB activation, we did EMSA as previously described (20) . The dried gels were visualized and radioactive bands quantitated with a PhosphorImager (Amersham Biosciences) and ImageQuant software (Molecular Dynamics).
Western blot analysis. To determine the levels of protein expression in the cytoplasm and the nucleus, we prepared extracts of TNF-treated cells from each and fractionated them by SDS-PAGE. After electrophoresis, the proteins were electrotransferred to a nitrocellulose membrane, blotted with each antibody, and detected by electrochemiluminescence reagents (Amersham Biosciences). The bands were quantitated with densitometry (Personal Densitometer Scan v1.30) and ImageQuant software version 3.3 (both from Molecular Dynamics; data not shown).
IKK assay. The IKK assay was done by a method described previously (17) .
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. The cell growth effects of TNF were determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) uptake method as described. Briefly, 2 Â 10 4 cells were seeded in triplicate in 96-well plates, pretreated with cycloheximide for 1 h, and then treated with various concentrations of TNF for 24 h at 37jC. Thereafter, MTT solution was added to each well. After a 2-h incubation at 37jC, an extraction buffer (20% SDS and 50% dimethylformamide) was added; the cells were then incubated overnight at 37jC, and the absorbance was measured at 570 nm by using a 96-well multiscanner (MRX Revelation; Dynex Technologies).
Annexin V assay. An early indicator of apoptosis is the rapid translocation and accumulation of the membrane phospholipid phosphatidylserine from the cytoplasmic interface to the extracellular surface. This loss of membrane asymmetry can be detected by using the binding Figure 1 . A, Western blot analysis of the NQO2 protein. Whole-cell extracts were prepared, resolved by SDS-PAGE, and electrotransferred to a nitrocellulose membrane, after which we did a Western blot analysis with an anti-NQO2 antibody. B, cell surface expression of TNFRs in NQO2 -WT and NQO2
À/À cells. Cells were harvested and resolved by SDS-PAGE, and electrotransferred to a nitrocellulose membrane, after which we did a Western blot analysis with anti-TNFR1 and anti-TNFR2 antibodies. C and D, time-dependent effects of NF-nB activation on NQO2 À/À cells treated with TNF. One million cells were treated with 0.1 nmol/L TNF for the indicated times, after which nuclear extracts were prepared; NF-nB activation was then analyzed by EMSA. E, dose-dependent effect of NF-nB activation in NQO2 À/À cells treated with TNF. One million cells were treated with the indicated concentrations of TNF for 30 min, after which nuclear extracts were prepared; NF-nB activity was then analyzed by EMSA.
The Role of NQO2 in TNF-Induced Signaling Pathway www.aacrjournals.org properties of Annexin V. Therefore, to identify apoptosis, we used the Annexin V antibody, which was conjugated with FITC fluorescence dye. Briefly, 1 Â 10 5 cells were pretreated with 1 Ag/mL cycloheximide, treated with 1 nmol/L TNF for 16 h at 37jC, and then subjected to Annexin V staining. Cells were washed in PBS, resuspended in 100 AL of a binding buffer containing FITC-conjugated anti-Annexin V antibody, and then analyzed with flow cytometry (FACSCalibur; BD Biosciences).
Results
We examined the expression of the NQO2 protein in both wildtype (NQO2-WT) and NQO2-null (NQO2 À/À ) murine keratinocytes.
As expected, NQO2 was expressed in NQO2-WT cells but not in NQO2 À/À cells (Fig. 1A) . We found no difference in the expression of TNF receptor (TNFR)-1 and TNFR2 with Western blot analysis in the two cell types (Fig. 1B) . NQO2 is required for TNF-dependent NF-KB activation. We first investigated the effect of NQO2 deletion on TNF-induced NF-nB activation. Cells were stimulated with 0.1 nmol/L TNF for indicated times; the nuclear extracts were prepared and were then analyzed for NF-nB activation by EMSA. As shown in Fig. 1C , TNF stimulated NF-nB activation in a time-dependent manner in NQO2-WT, but its activation was completely abrogated in NQO2 À/À cells. Cytoplasmic extract was prepared, resolved by SDS-PAGE, and electrotransferred to a nitrocellulose membrane, after which Western blot analysis with an anti-InBa antibody was done. B, effects of NQO2 deletion on TNF-induced activation of IKK. Four million cells were stimulated with 1 nmol/L TNF for the indicated times. Whole-cell extracts were incubated with anti-IKK-a antibody for 2 h, immunoprecipitated with protein A/G-Sepharose beads overnight at 4jC, and then analyzed with an immunocomplex kinase assay using glutathione S -transferase-InB (GST-IjB) as substrate. To examine the level of expression of IKK proteins, the same whole-cell extracts were resolved by SDS-PAGE, after which we did a Western blot analysis by using anti-IKK-a and anti-IKK-h antibodies. C, effects of NQO2 deletion on TNF-induced phosphorylation and nuclear translocation of the p65 subunit of NF-nB in cytoplasm. One million cells were treated with 0.1 nmol/L TNF for the indicated times; a cytosol extract was prepared, resolved by SDS-PAGE, and electrotransferred to a nitrocellulose membrane, after which a Western blot analysis was done by using anti-phosphospecific p65 antibody. The results shown are representative of three independent experiments. D, effects of NQO2 deletion on TNF-induced nuclear translocation of the p65 subunit of NF-nB in nucleus. One million cells were treated with 0.1 nmol/L TNF for the indicated times; a nuclear extract was prepared, resolved by SDS-PAGE, and electrotransferred to a nitrocellulose membrane, after which a Western blot analysis was done by using an anti-p65 antibody. The results shown are representative of three independent experiments. Four million cells were treated with 1 nmol/L TNF for the indicated times, after which whole-cell extracts were prepared, incubated with anti-JNK1 antibody for 2 h, and then immunoprecipitated with protein A/G-Sepharose beads overnight at 4jC. The beads were washed and subjected to a kinase assay as described in Materials and Methods. The same protein extracts were resolved by SDS-PAGE and electrotransferred to a nitrocellulose membrane, after which we did a Western blot analysis by using an anti-JNK1 antibody. B to D, effects of NQO2 deletion on TNF-induced activation of Akt, p38 MAPK, and p42/44 MAPK. One million cells were treated with 1 nmol/L TNF for the indicated times; whole-cell extracts were prepared, resolved by SDS-PAGE, and electrotransferred to a nitrocellulose membrane, after which Western blot analyses using phosphospecific anti-Akt, phosphospecific anti-p38 MAPK, and phosphospecific anti-p42/44 MAPK antibodies were done. The same membranes were reblotted with anti-Akt, anti-p38 MAPK, and p42/44 MAPK antibodies. The results shown are representative of three independent experiments.
Because the activation of NF-nB by TNF is more robust at higher concentrations (21), we evaluated the effect of NQO2 deletion on NF-nB activation induced by varying concentrations of TNF. The activation of NF-nB by TNF in the 0.01 to 1 nmol/L range was strongly evident in NQO2-WT cells but not in NQO2 À/À cells (Fig. 1D) . These results indicate that NQO2 is required for TNF-induced NF-nB activation.
NQO2 is required for TNF-dependent IKBA degradation. Translocation of NF-nB to the nucleus is preceded by proteolytic degradation of InBa (22) . To determine whether inhibition of TNF-induced NF-nB activation in NQO2 À/À cells was due to inhibition of InBa degradation, we exposed cells to TNF for various intervals and assayed degradation of InBa by Western blot analysis. TNF induced InBa degradation, reaching maximum at 10 to 30 min Fig. 2A, left) . In NQO2 À/À cells, however, TNF had no effect on InBa degradation ( Fig. 2A,  right) , indicating that NQO2 is required for degradation of InBa.
NQO2 deletion inhibits TNF-induced IKK activation. Given that IKK is required for TNF-induced NF-nB activation (22), we investigated the effect of NQO2 deletion on TNF-induced IKK activation. NQO2 À/À cells completely lacked TNF-induced activation of IKK, whereas the expression of IKK-a and IKK-h proteins in both wild-type and null cells was equivalent (Fig. 2B) . These results suggested that NQO2 is required for TNF-induced IKK activation. NQO2 is required for TNF-induced phosphorylation and nuclear translocation of p65. Because the degradation of InBa leads to nuclear translocation of the p65 subunit of NF-nB, we also analyzed the effect of the NQO2 deletion on TNF-induced nuclear translocation of p65 with Western blot analysis. In the cytoplasm, TNF induced phosphorylation of p65 as early as 10 min in NQO2-WT cells. After 30 min, the fold of activation was 2.4-fold. In NQO2 À/À cells, TNF did not induce the phosphorylation of p65 compared with control (Fig. 2C, top) . As shown in Fig. 2D , TNF also induced translocation of p65 in a time-dependent manner as early as 10 min after TNF stimulation in NQO2 -WT cells. In NQO2 À/À cells, TNF failed to induce phosphorylation of p65 in nuclei. NQO2 is required for TNF-induced activation of JNK. We investigated the role of NQO2 on other signals transduced by TNF. To examine the specific role of NQO2 on TNF-induced JNK activation, one of the earliest events induced by TNF (18), we stimulated cells with TNF for various time intervals, prepared whole-cell extracts, and analyzed them for JNK activity with an immunecomplex kinase assay. TNF induced the maximum activation (4.3-fold) of JNK at 15 min in NQO2-WT but in NQO2 À/À cells, almost no activation was observed (Fig. 3A) . These results indicated that NQO2 is required for TNF-induced JNK activation. NQO2 is required for TNF-induced activation of Akt. To examine the specific role of NQO2 on TNF-induced Akt activation, another early event induced by TNF (23), we exposed cells with TNF for indicated time intervals, prepared whole-cell extracts, and assayed them for phosphorylation of Akt by Western blot analysis. TNF induced activation of Akt in NQO2-WT but not in NQO2 À/À cells (Fig. 3B) . These results indicated that NQO2 is needed for TNF-induced Akt activation.
NQO2 is required for TNF-induced activation of p38. The activation of p38 has been associated with TNF-induced InB phosphorylation and NF-nB activation (24) . TNF induced activation of p38 in NQO2-WT (f2-fold) but in NQO2 À/À cells, it remained same as to the control (Fig. 3C) . These results indicated that NQO2 is needed for TNF-induced p38 activation. NQO2 is required for TNF-induced activation of p44/p42 MAPK. TNF has been reported to activate p44/p42 MAPK through the Ras/Raf/MAPK kinase cascade (18) . TNF induced the timedependent phosphorylation of p44/p42 MAPK in NQO2-WT but p44/p42 MAPK activation was abolished in NQO2 À/À cells (Fig. 3D) . These results suggested that NQO2 is also needed for TNF-induced p44/p42 MAPK activation. TNF increases NQO2 enzyme activity in wild-type keratinocytes and HepG2 cells. Our results thus far suggest that NQO2 plays a major role in TNF signaling. Next, we determined whether TNF activates NQO2 activity. NQO2 enzyme activity was measured in NQO2-WT keratinocytes (Fig. 4A, left) . Treatment of these cells with TNF resulted in a time-dependent increase in the NQO2 enzyme activity. Whether TNF activates NQO2 in cells other than keratinocytes was also examined. We found that TNF also caused a time-dependent induction of NQO2 activity in human hepatoblastoma HepG2 cells (Fig. 4A, right) .
Abrogation of NQO2 expression by siRNA inhibits TNFinduced NF-nB activation. All studies of the role of NQO2 in TNF signaling up to this point used genetically deleted NQO2 cells. Whether the suppression of NQO2 expression by siRNA would also abrogate TNF signaling was investigated next. NQO2 siRNA was used to knock down NQO2 protein expression in human hepatoblastoma HepG2 cells. NQO2 expression was effectively abolished in the cells treated with NQO2 siRNA but not in those treated with the scrambled siRNA, as observed by Western blot analysis (Fig. 4B) . TNF failed to induce the NQO2 activity in cells transfected with NQO2 siRNA (Fig. 4C) , and this correlated with inhibition of TNF-induced NF-nB activation (Fig. 4D) . Thus, these results with NQO2 siRNA also show the critical role of NQO2 in TNF signaling.
NQO2 is required for expression of TNF-induced, NF-KBdependent MMP-9, cyclin D1, and COX-2 proteins. Given that TNF induces cyclin D1, COX-2, and MMP-9 (25-27) expression, we examined whether NQO2 is needed for the induction of these gene products. Cells were treated with TNF for different intervals, whole-cell extracts were prepared, and the extracts analyzed by Western blot analysis for the expression of MMP-9, cyclin D1, and COX-2 (Fig. 5A ). All these were induced by TNF in a timedependent manner in NQO2-WT but not in NQO2 À/À cells.
NQO2 is required for expression of TNF-induced NF-KBdependent antiapoptotic proteins. Because NF-nB also regulates the expression of various antiapoptotic proteins, including IAP1/2, Bcl-2, XIAP, and cFLIP (28-30), we investigated the effect of NQO2 on the TNF-induced expression of these antiapoptotic gene products. TNF induced the expression of IAP1/2, Bcl-2, XIAP, and cFLIP in a time-dependent manner in NQO2-WT but not in NQO2 À/À cells (Fig. 5B) . These results indicated that NQO2 is required for TNF-induced NF-nB-regulated survival gene products.
Deletion of NQO2 potentiates TNF-induced apoptosis. Activation of NF-nB has been shown to inhibit TNF-induced apoptosis and promote proliferation through the expression of the previously mentioned gene products (31) (32) (33) . Our results suggest that deletion of NQO2 might enhance apoptosis induced by TNF through suppression of NF-nB-regulated antiapoptotic gene products. Whether suppression of NF-nB by NQO2 deletion affects Figure 6 . A, effect of NQO2 deletion on TNF-induced cell growth. Cells (2 Â 10 4 per well) were seeded in triplicate in 96-well plates, pretreated with cycloheximide (CHX; 1 Ag/mL) for 1 h, and then exposed to the indicated concentrations of TNF for 24 h. Thereafter, cell growth was analyzed by the MTT assay as described in Materials and Methods. Points, mean from triplicate cultures; bars, SD. B, cells (1 Â 10 5 per well) were pretreated with 1 Ag/mL cycloheximide for 1 h, incubated with 1 nmol/L TNF for 12 h, and then subjected to Annexin V staining. Cells were washed, incubated with a FITC-conjugated anti-Annexin V antibody, and then analyzed by flow cytometry. C, cells (1 Â 10 6 per well) were pretreated with 1 Ag/mL cycloheximide for 1 h, and incubated with indicated concentrations of TNF for 16 h. Whole-cell extracts were prepared, resolved by SDS-PAGE, and electrotransferred to a nitrocellulose membrane, after which we did a Western blot analysis with an anti-PARP antibody. D, the role of NQO2 in TNF signaling. The model suggests the role of NQO2 in TNF-induced activation of NF-nB, JNK, p38, p42/p44 MAPK, Akt, and apoptosis.
The Role of NQO2 in TNF-Induced Signaling Pathway www.aacrjournals.org TNF-induced apoptosis was therefore investigated. MTT assay showed that TNF was cytotoxic to cells and that NQO2 deletion enhanced that cytotoxicity (Fig. 6A) .
The results of Annexin V staining to determine whether this suppressed cell proliferation was due to apoptosis showed that TNF-induced apoptosis in 9% of NQO2-WT cells and 88% of NQO2 À/À cells (Fig. 6B) . The PARP cleavage assay showed that NQO2 deletion potentiated TNF-induced caspase activity (Fig. 6C ). All these assay results suggested that NQO2 deletion potentiates TNF-induced apoptosis.
Discussion
This study was designed to investigate the role of NQO2 on TNFinduced cell signaling. We found that TNF induced NF-nB activation, IKK activation, InBa degradation, p65 phosphorylation, and p65 translocation in NQO2-WT but not in NQO2 (Fig. 6D) .
Our results are the first to show that deletion of the NQO2 gene abolished TNF-induced NF-nB activation. Iskander et al. (34) found that lipopolysaccharide-induced NF-nB activation was suppressed in NQO2 À/À mice compared with wild-type mice and indicated that the suppression was caused by the loss of NF-nB expression (34) . However, we found that NQO2 À/À clearly suppressed TNFinduced NF-nB activation compared with NQO2-WT cells without the loss of NF-nB expression, suggesting that NQO2 is involved in TNF-induced cell signaling. We also found that TNF activated NQO2 activity in different cell types. NQO2-specific siRNA abolished the expression of NQO2 protein and abrogated TNFinduced NQO2 activity and NF-nB activation.
Although how NQO2 plays a role in TNF-induced NF-nB activation is not clear, the alteration of the redox status of the cell by NQO2 presumably regulates activation of redox-sensitive transcription factor(s), such as NF-nB (35) . This is in agreement with earlier observations from our laboratory that overexpression of the antioxidant enzymes superoxide dismutase (36) and g-glutamyl cysteine synthetase (37) can abolish TNF-induced cell signaling, including NF-nB activation. Thus, our results suggest that the deletion of NQO2 leads to altered intracellular redox status that results in the suppression of NF-nB activation. Intriguingly, deletion of the NQO1 gene leads to a similar phenotype, suggesting a nonredundant role for NQO1 and NQO2 in TNF-induced activation of NF-nB (17) .
Our results indicate that deletion of NQO2 abolished TNF-induced InBa degradation and phosphorylation through inhibition of IKK activation. How the deletion of NQO2 leads to suppression of IKK activation, however, is unclear, partly because the kinase that activates IKK is unknown. NIK, MEKK1, MEKK3, Akt, transforming growth factor-h-activated kinase 1, glycogen synthase kinase 3h (GSK-3h), NQO1, MKK4, and PKR have been shown to be involved in the IKK activation induced by TNF (17, (38) (39) (40) (41) (42) . Sarbassov et al. (43) recently reported that rictor kinase phosphorylates Akt, which in turn can activate IKK, leading to InBa phosphorylation and NF-nB activation. We found that TNF-induced Akt activation was indeed abrogated by deletion of the NQO2 gene.
Resveratrol, an active constituent found in cranberry, red grapes, and nuts, has been shown to modulate NQO2 activity in two different ways. First, resveratrol suppresses melanoma cell proliferation through the induction of NQO2 protein and activity (44) . Second, resveratrol is also a potent inhibitor of NQO2 activity in vitro with a dissociation constant of 35 nmol/L (45, 46) . Our group has already shown that resveratrol suppresses TNF-induced activation of NF-nB and AP-1 through down-modulation of reactive oxygen intermediate generation and lipid peroxidation (47) . Here, we also found that besides NF-nB activation, TNF-induced JNK activation was also abolished in NQO2 À/À cells. These results are in agreement with Manna et al. (47) , who showed that resveratrol, a specific NQO2 inhibitor, significantly suppressed TNF-induced AP-1 activation because JNK activation causes the activation AP-1. Moreover, we established for the first time that NQO2 À/À also abolishes TNF-induced activation of Akt, p38, and p44/p42 MAPK. These results parallel those of our previous reports, in which we showed that NQO2 À/À and GSK-3h abolished TNF-induced activation of Akt and MAPK factors (17, 41) . Although the role of these genes differ from each other in response to stimuli, it is possible that these genes have similar TNF-induced responses.
Our results also show for the first time that the expression of various NF-nB-dependent gene products, including COX-2, cyclin D1, MMP-9, IAP1, IAP2, Bcl-2, XIAP, and cFLIP is abolished in NQO2 À/À cells. The down-regulation of these gene products suggests that deletion of NQO2 suppresses TNF-induced proliferation and enhances apoptosis. Indeed, we found that in NQO2
À/À cells, TNF-induced cell proliferation was inhibited and apoptosis increased significantly. Other studies indicate that the deletion of NQO2 increases sensitivity to skin carcinogenesis and suppresses apoptosis of bone marrow cells (6, 7, 34) . NF-nB activation, however, has been linked with suppression of apoptosis, cellular proliferation, invasion, angiogenesis, and metastasis (30) . Thus, suppression of NF-nB activation by deletion of NQO2 seems to be paradoxical. However, most agents mediate opposite pathways, depending on other factors such as cell type. For instance, although TNF induces apoptosis in some cells, it induces the proliferation of others (18) . Recently, it has been reported that NQO2 activity of ovarian tissues is higher than in bladder samples, indicating that a potential role of the gene in the treatment of tumor (48) . Although various pro-oxidants can modulate both NF-nB and NQO2 activity, it is less clear whether the expression of NQO2 requires NF-nB activation. However, given that TNF and NF-nB are involved in the several disease states, including cancer, inflammation, diabetes, and neurodegenerative disorders (30, 49) , the potential of suppressing the TNF cell-signaling pathway by using NQO2 inhibitors exists (47) . Thus, our results show that NQO2 can regulate TNF-induced apoptosis through the NF-nB-regulated gene products, indicating that NQO2 plays a pivotal role in TNF-induced signaling pathway and that its suppression is a potential therapeutic approach in tumor cells.
